PCT
LTD Expands Production Capacity and
Accelerates
Hypochlorous
Acid
Production
and Sales
Little
River, SC -- March 25, 2020 -- InvestorsHub NewsWire
-- PCT LTD (OTC Pink: PCTL) ("PCTL") is continuing
to
expand business operations at a rapid rate while experiencing a
dramatic increase in inquiries and orders from new and existing
clients.
Following
up on
an
earlier release from March 18th;
a second
10,000-gallon
fluid
order has been shipped to an existing customer
in
the Midwest. Recurring orders to this sub-registrant are expected
to follow in the coming weeks.
"The
demand for our products has been nothing short of explosive,"
explains CEO Gary Grieco. "Due
to this high demand, we
are shifting
our
focus,
in
the short term,
towards
fluid production, sales,
and distribution."
The
company has
shifted its focus
towards
fulfilling
an increasing number of fluid orders. To meet this
growing demand, PCTL
is
expanding its production capacity and will
double
their current fluid production output within the next week to ten
days.
Jody
Read, COO stated: "We
are still continuing to
see significant
interest in the facility-based
Annihilyzer®
Infection Control
System. However,
we are
not able to coordinate installations due to travel restrictions and
availability of hospital staff to implement the
systems.
We are
continuing to build systems and at the same time utilize our
current South Carolina facility's capabilities with large volume
systems to produce mass quantities of disinfectant for distributors
and hospitals. PCT's
previous investment in building large volume systems and the
testing facility was easily modified into a fluid production
operation with little to no additional expense.
In
addition, we are continuing to engage suppliers to propagate the
pipeline of systems in process."
"We're
adding additional production and support personnel to our growing
team," says PCT Corp. President Bill Prince. "Currently, we
are focusing our
efforts on providing a much-needed
solution for our
clients and our communities. Our disinfecting solutions
offer an elevated
level of safety for
patients, healthcare professionals, and support staff to be around;
while at the same time providing an effective weapon in the fight
against infection."
The
Annihilyzer®
Infection Control
System remains the company's flagship product and continues to
garner intense interest from prospective hospitals and healthcare
facilities.
CEO
Gary Grieco adds.
"We're temporarily adjusting our focus towards where we can have
the biggest impact. With everything going on in the country right
now, we have a tremendous opportunity to not only grow as a
business, but to help our fellow Americans in their time of
need."
Due to
increased attention as a result of the ongoing coronavirus
pandemic, PCTL
has
been on an accelerated pace towards profitability and is preparing
for double-digit growth into Q2 and beyond.
"Growth
has been tremendous," says CFO Marion Sofield, adding that the
company is expecting to report record sales and revenues in Q1
2020. "We
are
working diligently on becoming current with our financial filings
and are eager to share information on current and ongoing events
with our shareholders. The world
looks
different today
than it did a few weeks ago. Many of the
professionals
involved with the filing of our financials find themselves
displaced or working from home under
these unusual circumstances. However, we are full steam ahead
on all fronts. Our reports are in the appropriate hands and
we expect to make all required filings as quickly as
possible."
Additional
News and Corporate Updates:
PCTL
would like to warn its stockholders and potential investors that
material corporate information regarding sales, areas of business
and other corporate updates will only be made through press
releases or filings with the SEC. PCTL does not utilize social
media, chatrooms or other online sources to disclose material
information. The
public should only rely on official press releases and corporate
filings for accurate and up to date information regarding
PCTL.
About
PCT LTD:
PCT LTD
("PCTL") focuses its business on acquiring, developing and
providing sustainable, environmentally safe disinfecting, cleaning
and tracking technologies. The company acquires and holds rights to
innovative products and technologies, which are commercialized
through its wholly-owned
operating
subsidiary, Paradigm Convergence Technologies Corporation (PCT
Corp). Currently trading on OTC, "PCTL" aspires to and is actively
engaged in preparations for up-listing
its
common stock to a national securities exchange. The Company
established entry into its target markets with commercially viable
products in the United States and now continues to gain market
share in the U.S. and U.K.
Forward-Looking
Statements:
This
press release contains "forward-looking statements" as defined in
Section 27A of the Securities Act of 1933, as amended, and Section
21B of the Securities Exchange Act of 1934, as amended. Any
statements that express or involve discussions with respect to
predictions, expectations, beliefs, plans, projections, objectives,
goals, assumptions or future events or performance are not
statements of historical fact and may be "forward-looking
statements."
Such
statements are based on expectations, estimates and projections at
the time the statements are made that involve a number of risks and
uncertainties, which could cause actual results or events to differ
materially from those presently anticipated. Such statements
involve risks and uncertainties, including but not limited
to: actual sales
derived by the Company;
the
transition to producing large quantities of
fluids; PCTL's and its
subsidiary's business prospects; PCTL's ability to raise sufficient
funds to satisfy its working capital requirements; the ability of
PCTL to execute its business plan; any other effects resulting from
the information disclosed above; risks and effects of legal and
administrative proceedings and government regulation; future
financial and operational results; competition; general economic
conditions; and the ability to manage and continue growth. Should
one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual outcomes may vary
materially from those indicated. Important factors that could cause
actual results to differ materially from the forward-looking
statements PCTL makes in this press release include market
conditions and those set forth in reports or documents it files
from time to time with the SEC. PCTL undertakes no obligation to
revise or update such statements to reflect current events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
Gary
Grieco, CEO and Chairman, PCT LTD
(843)
390-7900 Office
(843)
390-2347 Fax
www.para-con.com
www.pctcorphealth.com
www.survivalyte.com
Brokers
and Analysts: Chesapeake Group
+1-410-825-3930
info@chesapeakegp.com